<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>02.08. Área de Salud VIII Mar Menor</title>
<link>https://sms.carm.es/ricsmur/handle/123456789/17187</link>
<description/>
<pubDate>Thu, 19 Nov 2026 23:10:14 GMT</pubDate>
<dc:date>2026-11-19T23:10:14Z</dc:date>
<item>
<title>Clinical Course and Predictors of Biologic Therapy, Hospitalisation and Surgery: A Five-Year Prospective Study in Newly Diagnosed Inflammatory Bowel Disease.</title>
<link>https://sms.carm.es/ricsmur/handle/123456789/29211</link>
<description>Clinical Course and Predictors of Biologic Therapy, Hospitalisation and Surgery: A Five-Year Prospective Study in Newly Diagnosed Inflammatory Bowel Disease.
Garre, Ana; Nunez-Ortiz, Andrea; Rubio, Saioa; Diz-Lois-Palomares, María-Teresa; Riestra, Sabino; Alonso-Galan, Horacio; Fernández-Salgado, Estela; Ferreiro-Iglesias, Rocio; Vela, Milagros; Ponferrada-Diaz, Angel; Sánchez-Rodríguez, Eugenia; Hernández, Vicent; Arias-García, Lara; Barrio, Jesús; Huguet, José-María; Ginard, Daniel; Rivero, Montserrat; Vera, Isabel; Alonso-Abreu, Inmaculada; Benitez, José-Manuel; Aguas, Mariam; Rodríguez-Lago, Iago; Calvet, Xavier; Fernández-Salazar, Luis; Echarri, Ana; Arroyo, María-Teresa; Navarro-Llavat, Merce; Vega, Pablo; Sierra, Mónica; Guerra-del-Rio, Elena; Vicente, Raquel; Casanova, María-José; Navarro, Pablo; de-Zarate, Jone-Ortiz; Trastoy, Pilar-Varela; Spicakova, Katerina; Gutiérrez, Ana; Martin-Arranz, María-Dolores; Pinero, Concepcion; Hernández-Martínez, Alvaro; Torrella-Cortés, Emilio; Marrero, José-Miguel; Lorente-Poyatos, Rufo-H; Marti-Romero, Lidia; Bosch, Orencio; Duque, José-María; Aceituno, Montserrat; Fernández, Hipolito; Crespo-Suarez, Belen; Fuentes-Coronel, Ana-María; Pozzati, Liliana; Robledo, Pilar; Sese-Abizanda, Eva; Herreros-Martínez, Belen; Jiménez, Nuria; López-Serrano, Pilar; Sampedro, Manuela-Josefa; Bermejo, Fernando; Lucendo, Alfredo-J; Munoz-Vicente, Margarita; Menacho, Margarita; Ramirez-Palanca, José-Joaquin; Camargo, Raquel; Carmona, Amalia; Torra-Alsina, Sandra; Calafat, Margalida; Forcelledo, José-Luis-F; Nerin-de-la-Puerta, Juan; Nicolás-de-Prado, Isabel; Opio, Veronica; Ber, Yolanda; Bouhmidi, Abdel; Abraldes-Bechiarelli, Alfredo; Castano-Milla, Carlos; Cruz, Noelia; Gordillo, Jordi; Sapina, Amparo; López, Alina; Rodríguez-Mondejar, Silvia; Novella-Duran, María-Teresa; Botella, Belen; Kutz, Marcos; Kolle, Lilyan; Marin-Jiménez, Ignacio; Martínez-Cerezo, Francisco-J; Irisarri, Rebeca; Iyo, Eduardo; Roncero, Oscar; Sabat, Miriam; Torres-Domínguez, Yolanda; Ledezma, Cesar; Zapata, Eva-María; Alcala, María-José; Lluis, Laia; Martínez-Pascual, Cristina; Blazquez-Gómez, Isabel; Hernández, Luis; Mata, Laura; Monrobel, Ana; Hernández-Camba, Alejandro; Maroto, Nuria; Tejada, María; Galve, María-Luisa; Montealegre, María; Hervias, Daniel; Soler, Marta; Gómez-Valero, José-Antonio; Barreiro-de-Acosta, Manuel; Soto-Escribano, Pilar; Cabriada, José-Luis; Ceballos, Daniel; Esteve, María; García-Rodríguez, Alba; Royo, Vanesa; Gomollon, Fernando; Verdejo-Gil, Cristina; Nos, Pilar; de-Francisco, Ruth; García, María-José; Duenas-Sadornil, Carmen; Rodríguez, Cristina; Sicilia, Beatriz; Fernández-Felix, Borja-M; Gisbert, Javier-P; Chaparro, María
AIMS: This study aimed to describe the characteristics of newly diagnosed inflammatory bowel disease (IBD) patients and to analyse their clinical course within the first 5 years after diagnosis, including the need for surgery, hospitalisations and treatments. METHODS: This prospective and large multicentre incident cohort registry in Spain enrolled adults diagnosed with Crohn's disease (CD), ulcerative colitis (UC) or unclassified IBD (IBD-U) in 2017 and followed them for 5 years. RESULTS: A total of 3301 patients were enrolled: 1526 with CD, 1633 with UC and 142 with IBD-U. Their median age at diagnosis was 43 years (interquartile range 31-56) and approximately 50% were male. Within 5 years post-diagnosis, 30% received biologics or JAK inhibitors (JAKi), 34% were hospitalised at least once and 9% underwent surgery. The cumulative incidence of biologic/JAKi treatment, hospitalisations and surgeries was higher among CD patients. Use of biologics/JAKi correlated with a more aggressive CD phenotype, greater UC extent and younger age at diagnosis. Biologics/JAKi treatment was associated with lower hospitalisation risk in both CD (Hazard ratio [HR] = 0.4, 95% confidence interval [CI] = 0.2-0.6) and UC patients (HR = 0.5, 95% CI = 0.2-0.9). However, it was not associated with the risk of abdominal surgery in CD but was linked to an increased risk of surgery in UC (HR = 11.9, 95% CI = 4.6-30.4). CONCLUSIONS: This large multicentre cohort demonstrated a higher use of biologics/JAKi during the first 5 years after IBD diagnosis than previously reported. Treatment with biologics/JAKi was associated with reduced risk of hospitalisation. However, under current clinical practice patterns, this therapeutic approach did not translate into lower risk of abdominal surgery.
</description>
<pubDate>Sun, 11 Oct 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://sms.carm.es/ricsmur/handle/123456789/29211</guid>
<dc:date>2026-10-11T00:00:00Z</dc:date>
</item>
<item>
<title>Stability Study of a Frozen Oseltamivir 15 mg/mL Oral Solution in Amber Glass Bottles</title>
<link>https://sms.carm.es/ricsmur/handle/123456789/29026</link>
<description>Stability Study of a Frozen Oseltamivir 15 mg/mL Oral Solution in Amber Glass Bottles
Ruiz-Ramírez, Juan-Carlos; Gómiz-Sáez, Adrián; Martínez-Madrid, María-Encarnación; Viney, Alice-Charlotte; Alonso-Herreros, José-María; Almela-Rojo, Pilar
</description>
<pubDate>Tue, 08 Sep 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://sms.carm.es/ricsmur/handle/123456789/29026</guid>
<dc:date>2026-09-08T00:00:00Z</dc:date>
</item>
<item>
<title>Stability Study of Meropenem 50 mg/mL Eye Drops in Polypropylene Dropper Bottles</title>
<link>https://sms.carm.es/ricsmur/handle/123456789/29019</link>
<description>Stability Study of Meropenem 50 mg/mL Eye Drops in Polypropylene Dropper Bottles
Ruiz-Ramírez, Juan-Carlos; Martínez-Madrid, María-Encarnación; Gómiz-Sáez, Adrián; Viney, Alice-Charlotte; Alonso-Herreros, José-María; Almela-Rojo, Pilar
</description>
<pubDate>Fri, 07 Aug 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://sms.carm.es/ricsmur/handle/123456789/29019</guid>
<dc:date>2026-08-07T00:00:00Z</dc:date>
</item>
<item>
<title>Frequency-Following Responses for Objective Neurophysiological Monitoring in Pediatric Fetal Alcohol Spectrum Disorder: A Proof of Concept Case Study During Non-Invasive Neuromodulation</title>
<link>https://sms.carm.es/ricsmur/handle/123456789/29017</link>
<description>Frequency-Following Responses for Objective Neurophysiological Monitoring in Pediatric Fetal Alcohol Spectrum Disorder: A Proof of Concept Case Study During Non-Invasive Neuromodulation
Templado, Sheila; Medina-Ramírez, Raquel; Savio, Guillermo; Almela-Rojo, María-Teresa; García-Purrinos, Francisco-José
</description>
<pubDate>Thu, 20 Aug 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">https://sms.carm.es/ricsmur/handle/123456789/29017</guid>
<dc:date>2026-08-20T00:00:00Z</dc:date>
</item>
</channel>
</rss>
